Pharmacological small molecules against prostate cancer by enhancing function of death receptor 5

HIGHLIGHTS

  • who: Xia Gan and collaborators from the Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, Wuhe Road, Qingxiu District, Nanning, China have published the paper: Pharmacological Small Molecules against Prostate Cancer by Enhancing Function of Death Receptor 5, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEWcolorectal, breast, and 13 Sulindal thyroid-free cancers of 30/07/2022
  • how: The results showed that the therapy did not cause grade 4 acute and late genitourinary toxicity but there were common grade 1 to 2 late toxicities such as proctitis . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?